Skip to main content
Premium Trial:

Request an Annual Quote

Smiths Detection Wins NIH Grant for Flu Dx

NEW YORK (GenomeWeb News)— Smiths Detection has received a $2.2 million grant from the National Institutes of Health to develop a PCR-based test for multiple influenza types in humans, the London-based company said.

The two-year grant from the National Institute of Allergy and Infectious Diseases will support development of a test that will use LATE PCR technology on the company’s Bio-Seeq instrument and may be administered at the point of care or in a conventional lab.

Smiths Detection licensed the LATE PCR nucleic acid amplification technology from Brandeis University.

The firm also is developing a similar test for diagnosing influenza infections in animals that will use desktop and portable versions of the Bio-Seeq system.

"The pandemic influenza application makes excellent use of the full range of our diagnostic technologies, combining the need for a sophisticated highly multiplexed test with the need for rapid results at the point of care," Bill Mawer, who heads Smith Detections diagnostics business, said in a statement.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.